Pricing Log in Create free account

SpyGlass Pharma, Inc. (SGP) vs Seaport Therapeutics, Inc (SPTX)

SpyGlass Pharma, Inc. and Seaport Therapeutics, Inc are both Biotechnology companies. SpyGlass Pharma, Inc. and Seaport Therapeutics, Inc are of similar size ($1.1B and $1.1B). Across the 9 metrics below, SpyGlass Pharma, Inc. leads on 6 and Seaport Therapeutics, Inc on 3.

Valuation

Metric SGP SPTX Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 5.24 2.85 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (24.85%) (107.07%) (32.88%)
Free cash flow yield (3.81%) (8.47%) (23.13%)

Profitability

Metric SGP SPTX Biotechnology median
Gross margin — — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (51.34%) (74.36%) (51.96%)
Return on assets (35.97%) (37.78%) (46.06%)
Return on invested capital 0.00% (88.12%) 0.00%

Growth

Metric SGP SPTX Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (10.25%) 36.55% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric SGP SPTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 25.06 17.48 4.97
Net debt to EBITDA 2.63 2.42 1.01

Dividend

Metric SGP SPTX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric SGP SPTX Biotechnology median
Market cap 1.14b 1.09b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack